Ben Tre Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DBT6
VND
10,650.00
-200 (-1.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,76,992.96
2,43,175.12
1,61,230.72
2,58,393.55
2,00,555.87
2,24,091.88
1,85,370.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,76,992.96
2,43,175.12
1,61,230.72
2,58,393.55
2,00,555.87
2,24,091.88
1,85,370.29
Raw Material Cost
1,03,821.55
1,51,080.45
86,315.01
1,51,927.38
1,30,033.14
1,40,608.79
1,11,894.81
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
28,105.06
40,064.30
41,520.02
0.00
35,536.62
43,975.75
37,835.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7,681.24
10,249.42
10,256.98
10,146.96
9,888.31
10,166.80
9,927.57
Selling and Distribution Expenses
65,855.48
69,182.48
62,155.01
91,297.33
61,384.33
71,177.47
61,797.56
Other Expenses
-3,578.63
-5,031.37
-5,177.70
-1,014.70
-4,542.49
-5,414.26
-4,776.29
Total Expenditure (Excl Depreciation)
1,69,677.02
2,20,262.93
1,48,470.02
2,43,224.71
1,91,417.47
2,11,786.26
1,73,692.37
Operating Profit (PBDIT) excl Other Income
7315.900000000001
22912.199999999997
12760.699999999999
15168.800000000001
9138.4
12305.599999999999
11677.9
Other Income
1,053.57
-693.20
759.15
787.19
2,653.11
1,197.96
6,763.42
Operating Profit (PBDIT)
13,418.25
26,771.58
18,135.61
20,811.97
15,342.59
16,914.59
23,592.96
Interest
7,681.24
10,249.42
10,256.98
10,146.96
9,888.31
10,166.80
9,927.57
Exceptional Items
-0.55
132.79
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
73,171.41
92,094.67
74,915.71
1,06,466.17
70,522.74
83,483.08
73,475.48
Depreciation
5,048.74
4,552.59
4,615.75
4,855.94
3,551.07
3,411.02
5,151.63
Profit Before Tax
687.71
12,102.36
3,262.88
5,809.07
1,903.20
3,336.78
8,513.77
Tax
93.27
2,544.43
1,219.17
1,230.88
1,341.12
1,943.01
2,406.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
578.03
10,355.06
2,655.74
4,260.14
2,033.22
927.89
7,396.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
578.03
10,355.06
2,655.74
4,260.14
2,033.22
927.89
7,396.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
16.41
-797.13
-612.04
318.06
-1,471.13
465.87
-1,288.94
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
594.44
9,557.93
2,043.71
4,578.20
562.08
1,393.77
6,107.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
2,76,224.42
2,75,627.84
2,68,100.09
2,65,444.35
2,39,059.09
2,55,089.95
2,47,252.08
Earnings per share (EPS)
26.31
471.37
120.89
193.93
102.1
46.6
371.41
Diluted Earnings per share
26.31
471.37
120.89
193.93
102.1
46.6
371.41
Operating Profit Margin (Excl OI)
4.13%
9.42%
7.91%
5.87%
4.56%
5.49%
6.3%
Gross Profit Margin
3.24%
6.85%
4.89%
4.13%
2.72%
3.01%
7.37%
PAT Margin
0.33%
4.26%
1.65%
1.65%
1.01%
0.41%
3.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is -11.75% vs 6.00% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 5.75% vs -8.65% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -2.56% vs -8.53% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -22.32% vs -7.22% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Ben Tre Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
1,76,992.96
2,26,268.15
-49,275.19
-21.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,76,992.96
2,26,268.15
-49,275.19
-21.78%
Raw Material Cost
1,03,821.55
1,78,351.86
-74,530.31
-41.79%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
28,105.06
0.00
28,105.06
Power Cost
0
0
0.00
Manufacturing Expenses
7,681.24
0.00
7,681.24
Selling and Distribution Expenses
65,855.48
63,618.56
2,236.92
3.52%
Other Expenses
-3,578.63
0.00
-3,578.63
Total Expenditure (Excl Depreciation)
1,69,677.02
2,41,970.42
-72,293.40
-29.88%
Operating Profit (PBDIT) excl Other Income
7,315.94
-15,702.27
23,018.21
146.59%
Other Income
1,053.57
6,012.96
-4,959.39
-82.48%
Operating Profit (PBDIT)
13,418.25
-9,689.31
23,107.56
238.49%
Interest
7,681.24
0.00
7,681.24
Exceptional Items
-0.55
0.00
-0.55
Gross Profit (PBDT)
73,171.41
47,916.29
25,255.12
52.71%
Depreciation
5,048.74
0.00
5,048.74
Profit Before Tax
687.71
-9,689.31
10,377.02
107.10%
Tax
93.27
0.00
93.27
Provisions and contingencies
0
0
0.00
Profit After Tax
578.03
-9,689.31
10,267.34
105.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
578.03
-9,689.31
10,267.34
105.97%
Share in Profit of Associates
0
0
0.00
Minority Interest
16.41
0.00
16.41
Other related items
0.00
0.00
0.00
Consolidated Net Profit
594.44
-9,689.31
10,283.75
106.14%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
2,76,224.42
12,26,008.19
-9,49,783.77
-77.47%
Earnings per share (EPS)
26.31
-383.46
409.77
106.86%
Diluted Earnings per share
26.31
-383.46
409.77
106.86%
Operating Profit Margin (Excl OI)
4.13%
-6.94%
0.00
11.07%
Gross Profit Margin
3.24%
-4.28%
0.00
7.52%
PAT Margin
0.33%
-4.28%
0.00
4.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17,699.30 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -27.22% vs 50.82% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -11.75% vs 6.00% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 59.44 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -93.78% vs 367.68% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.75% vs -8.65% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,236.47 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -54.98% vs 58.06% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -2.56% vs -8.53% in Sep 2024

Quarterly - Interest
Interest 768.12 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -25.06% vs -0.07% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -22.32% vs -7.22% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.13%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024